Pemvidutide vs UBT251
Head-to-head comparison of Pemvidutide (Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) and UBT251 (UBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Pemvidutide | UBT251 |
|---|---|---|
| Category | Weight Management | Weight Management |
| Full Name | Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist | UBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist |
| Molecular Weight | N/A | N/A |
| Half-Life | Approximately 1 week | Approximately 1 week |
| Amino Acids | N/A | N/A |
| Typical Dose | Trial-dependent; once-weekly SC titration | Investigational; no established human dose |
| Route | Subcutaneous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 18 | 8 |
| Research Status | Clinical | Pre-clinical |
Pemvidutide Benefits
- ✓appetite suppression
- ✓body-weight reduction
- ✓improved liver-fat markers
- ✓better glycemic control
UBT251 Benefits
- ✓weight reduction
- ✓improved satiety
- ✓enhanced energy expenditure
- ✓better insulin sensitivity
Pemvidutide Dosing
once-weekly subcutaneous injection|gradual dose escalation|maintenance at tolerated trial dose
UBT251 Dosing
once-weekly subcutaneous injection|dose escalation in studies|maintenance after tolerability assessment
Pemvidutide Side Effects
- ⚠nausea
- ⚠vomiting
- ⚠diarrhea
UBT251 Side Effects
- ⚠nausea
- ⚠diarrhea
- ⚠fatigue
Research Overview
Pemvidutide
Clinical studies have reported dose-dependent weight loss and favorable effects on liver fat and transaminases. It remains investigational and is not approved for obesity treatment.
UBT251
Published work supports strong anti-obesity activity in preclinical models, with translation into human studies still emerging. The compound remains investigational and is best characterized as an early multi-agonist program.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.